StockVS

NASDAQ · Medical Care Facilities · USD

NewGenIvf Group Limited (NIVF) Stock Analysis

NewGenIvf Group Limited (NIVF) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

NIVF

$1.14

−$0.04 (−3.39%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NIVF with… →

NIVF Key Statistics

As of Sep 4, 2026
Trading
Open
$1.17
Previous Close
$1.18
Day's Range
1.11–1.18
52-Week Range
1.11–1,539.00
Volume
64.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.04
Valuation
Market Cap
$2.43M
P/E Ratio
0.00
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
0.01
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.52
EPS (ttm)Profit attributable to each share over the last twelve months.
328.32
Financials (FY)
Revenue (FY)
$4.73M−13.01%
Net Income (FY)
$9.88M
Profit marginThe share of revenue left as profit after all costs and taxes.
209.03%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
2.12M
1-Year Return
−99.64%
Dividend and dates
Avg Volume
475.10K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NIVF Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−95.41%
2025−99.32%
2024−96.28%
2023+6.86%
2022 (partial year)+3.76%

As of September 4, 2026.

NIVF Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$4.73M$9.88M209.0%
2024$5.43M−$524.64K−9.7%
2023$5.14M$130.19K2.5%
2022$5.94M$458.67K7.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.73M$955.85K−$10.73M$9.88M209.0%
2024$5.43M$1.83M−$1.16M−$524.64K−9.7%
2023$5.14M$1.68M$42.24K$130.19K2.5%
2022$5.94M$1.54M$398.71K$458.67K7.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NIVF Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricNIVFMedical Care Facilities medianvs median
P/E0.0019.840.0x the median
P/S ratio0.520.9546% below
Profit margin209.03%3.06%206.0 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

NewGenIvf Group Limited (NIVF) is capitalised at $2.43M on the latest close. It is classified in the Medical Care Facilities industry, within the Healthcare sector. Headcount on file is 87.

Over the past 52 weeks the price has ranged from $1.11 to $1,539.00. NIVF last closed at $1.14 on September 4, 2026. That is −$0.04 (−3.39%) against the previous close. The latest close sits 2.7% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.73M. That is −13.01% against the prior fiscal year, when revenue was $5.43M. The same year closed with net income of $9.88M. Profit margin runs at 209.03%. That is 206 percentage points above the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to 328.32.

Across the 4 fiscal years on file, revenue moves from $5.94M in 2022 to $4.73M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 0. On forward earnings the ratio is 0.01. The price-to-sales ratio is 0.52. On price-to-sales that is 45.81% below the Medical Care Facilities median of 0.95. 57 Medical Care Facilities companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is −99.64%. Across 3 years the annualized return works out at −97.72%. Beta against the wider market is reported at −0.04. Daily returns over the trailing 4 years annualize to a volatility of 819%.

Growth & Income

No dividend is on file for NIVF.

The strongest complete calendar year on file is 2023 at +6.86%; the weakest is 2025 at −99.32%. Of the 3 complete calendar years on file, 1 finished higher. So far in 2026 the price is −95.41%.

Peer Comparison

NewGenIvf Group Limited (NIVF) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
NewGenIvf Group Limited NIVF $2.43M 0.0
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. NewGenIvf Group Limited trades at a P/E of 0.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

View all Medical Care Facilities stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About NewGenIvf Group Limited

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Visit website →